Yorktown Management & Research CO Inc Repligen Corp Transaction History

Yorktown Management & Research CO Inc

$102 Million
Q1 2024

A detailed history of Yorktown Management & Research CO Inc transactions in Repligen Corp stock. As of the latest transaction made, Yorktown Management & Research CO Inc holds 3,050 shares of RGEN stock, worth $368,348. This represents 0.55% of its overall portfolio holdings.

Number of Shares

3,050

Previous 3,050 -0.0%

Holding current value

$368,348

Previous $548,000 2.19%

% of portfolio

0.55%

Previous 0.59%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 26, 2023	SELL	$138.78 - $176.51 $485,730 - $617,785	-3,500 Reduced 53.44%	3,050 $484,000
Q2 2023 Jul 28, 2023	SELL	$138.42 - $180.31 $166,103 - $216,372	-1,200 Reduced 15.48%	6,550 $926,000
Q2 2022 Jul 29, 2022	SELL	$140.68 - $188.02 $323,564 - $432,446	-2,300 Reduced 22.89%	7,750 $1.26 Million
Q1 2022 Apr 29, 2022	SELL	$161.19 - $257.96 $161,190 - $257,959	-1,000 Reduced 9.05%	10,050 $1.89 Million
Q4 2021 Feb 09, 2022	BUY	$247.59 - $304.47 $247,590 - $304,470	1,000 Added 9.95%	11,050 $2.93 Million

Q2 2021 Aug 03, 2021	BUY	$165.87 - $220.95 $132,696 - $176,760	800 Added 8.65%	10,050 $2.01 Million
Q1 2021 May 11, 2021	BUY	$180.37 - $226.26 $18,037 - $22,626	100 Added 1.09%	9,250 $1.8 Million
Q3 2020 Nov 06, 2020	BUY	$122.51 - $158.27 $122,510 - $158,270	1,000 Added 12.27%	9,150 $1.35 Million
Q2 2020 Aug 11, 2020	BUY	$94.33 - $140.48 $23,582 - $35,120	250 Added 3.16%	8,150 $1.01 Million
Q4 2019 Jan 27, 2020	BUY	$73.84 - $93.08 $23,628 - $29,785	320 Added 4.22%	7,900 $731,000
Q1 2019 May 13, 2019	BUY	$49.45 - $62.8 $374,831 - $476,024	7,580 New	7,580 $448,000

Others Institutions Holding RGEN

# of Institutions

522

Shares Held

53.2M

Call Options Held

1.05M

Put Options Held

228K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $6.7B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Yorktown Management & Research CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Yorktown Management & Research CO Inc with notifications on news.

Account

Yorktown Management & Research CO Inc Repligen Corp Transaction History